{
    "title": "U.S. secures 600,000 more doses of GSK-Vir's COVID-19 therapy",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10390515/U-S-buy-600-000-doses-GSK-Virs-COVID-19-antibody-therapy.html",
    "date": "2022-01-11",
    "keywords": [
        "omicron",
        "country",
        "sotrovimab",
        "aripaka",
        "gsk",
        "vir",
        "covid19",
        "therapy",
        "coronavirus",
        "government",
        "number",
        "treatment",
        "drug",
        "total",
        "jan",
        "biotechnologys",
        "antibody",
        "sum",
        "arsenal",
        "quarter",
        "tuesday",
        "tally",
        "canada",
        "union",
        "november",
        "distribution",
        "class",
        "bodys",
        "fastspreading",
        "httpswwwreuterscombusinesshealthcarepharmaceuticalswhoseesmoreevidencethatomicronaffectsupperrespiratorytract20220104",
        "monday",
        "role",
        "response",
        "martinezdavis",
        "head",
        "urgency",
        "supply",
        "capacity",
        "variant",
        "protection",
        "week",
        "administration",
        "order",
        "sheer",
        "patient",
        "staff",
        "half",
        "infusion",
        "trial",
        "shot",
        "arm",
        "emergency",
        "use",
        "httpswwwreuterscombusinesshealthcarepharmaceuticalsusfdagivesemergencyuseapprovalgskvircovid19antibodydrug20210526",
        "mild",
        "reporting",
        "pushkala",
        "bengaluru",
        "editing",
        "ramakrishnan",
        "tomasz",
        "janowski"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}